Tgf-β1, Tgf-β2, Tgf-β3 and Msx2 expression is elevated during frontonasal suture morphogenesis and during active postnatal facial growth

Orthodontics and Craniofacial Research

Volumn 5, Issue 4, 2002, Pages 227-237

  Adab, K ^a,b   Sayne, J R ^a   Carlson, D S ^a   Opperman, L A ^a   Opperman, Lynne A ^a  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Craniofacial sutures; Facial growth; Morphogenesis; Msx2; Transforming growth factor s

Indexed keywords

DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR MSX2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CRANIAL SUTURE; FRONTAL BONE; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; MAXILLOFACIAL DEVELOPMENT; METABOLISM; MORPHOGENESIS; NASAL BONE; PRENATAL DEVELOPMENT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; CRANIAL SUTURES; DNA-BINDING PROTEINS; FRONTAL BONE; GENE EXPRESSION; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; MAXILLOFACIAL DEVELOPMENT; MORPHOGENESIS; NASAL BONE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0036831913     PISSN: 16016335     EISSN: 16016343     Source Type: Journal    
DOI: 10.1034/j.1600-0544.2002.02227.x     Document Type: Article

References (32)

1. Cohen MM Jr. Sutural biology and the correlates of craniosynostosis. Am J Med Genet 1993;47:581-616.
2. Cohen MM Jr. Suture biology. In: Cohen MM Jr, MacLean RE, editors. Craniosynostosis, Diagnosis, Evaluation and Management, 2nd edn, eds. New York: Oxford University Press; 2000. pp. 11-23.
3. Kreiborg S. Postnatal growth and development of the craniofacial complex in premature craniosynostosis. In: Cohen MM Jr, Maclean, RE, editors. Craniosynostosis, Diagnosis, Evaluation and Management, 2nd edn. New York: Oxford University Press; 2000. pp. 158-74.
4. Opperman LA, Sweeney TM, Redmon J, Persing JA, Ogle RC. Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev Dynam 1993;198:312-22.
5. Opperman LA, Passarelli RW, Morgan EP, Reintjes M, Ogle RC. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J Bone Min Res 1995;10:1978- 87.
6. Kim HJ, Rice DP, Kettunen PJ, Thesleff I. FGF-, BMP- and Shhmediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 1998;125:1241-51.
7. Opperman LA, Passarelli RW, Nolen AA, Gampper TJ, Lin KY, Ogle RC. Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis. In Vitro Cell Dev Biol 1996;32:627-32.
8. Opperman LA, Nolen AA, Ogle RC. TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro (see comments). J Bone Min Res 1997;12:301-10.
9. Roth DA, Longaker MT, McCarthy JG, Rosen DM, McMullen HF, Levine JP, Sung J, Gold LI. Studies in cranial suture biology: Part I. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion (see comments). J Bone Min Res 1997b;12:311-21.
10. Rice DP, Kim HJ, Thesleff I. Apoptosis in murine calvarial bone and suture development. European J Oral Sci 1999;107:265-75.
11. Roth DA, Gold LI, Han VK, McCarthy JG, Sung JJ, Wisoff JH, Longaker MT. Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion (see comments). Plast Reconstr Surg 1997a;99:300-9; discussion 310-6.
12. Opperman LA, Adab K, Gakunga PT. TGF-B2 and TGF-B3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev Dynam 2000;219:237-47.
13. Opperman LA, Chhabra A, Cho RW, Ogle RC. Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro. J Craniofac Genet Dev Biol 1999;19:164-73.
14. Opperman LA, Chhabra A, Nolen AA, Bao Y, Ogle RC. Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production. J Craniofac Genet Dev Biol 1998;18:150-8.
15. Jabs EW, Li X, Scott AF, Meyers G, Chen W, Eccles M, Mao JI, Charnas LR, Jackson CE, Jaye M. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2 [published erratum appears in Nat Genet 1995 April; 9(4): 451]. Nat Genet 1994;8:275-9.
16. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 1994;8:269-74.
17. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 1994;8:98-103.
18. Myers GA, Orlow SJ, Munro JR, Przylepa KA, Jabs EW. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 1995;11:462-4.
19. Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome (see comments). Nat Genet 1995;9:165-72.
20. Bellus GA, Gaudenz K, Zackai EH, Clarke LA, Szabo J, Francomano CA, Muenke M. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet 1996;14: 174-6.
21. Jabs EW, Muller U, Li X, Ma L, Luo W, Haworth IS, Klisak I, Sparkes R, Warman ML, Mulliken JB. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993;75: 443-50.
22. Ma L, Golden S, Wu L, Maxson R. The molecular basis of Bostontype craniosynostosis: the Pro148His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences. Hum Molec Genet 1996;5:1915-20.
23. Mohammed CI. Growth pattern of the rat maxilla from 16 days insemination age to 30 days after birth. Am J Anat 1957;100:115- 65.
24. Persson M. The role of sutures in normal and abnormal craniofacial growth. Acta Ortho Scand 1995;53:152-61.
25. McPherson GK, Kriewall TJ. Fetal head molding. an investigation utilizing a finite element model of the fetal parietal bone. J Biomechanics 1980;13:17-26.
26. Massler M, Schour I. The growth pattern of the cranial vault in the albino rat as measured by vital staining with alizarin red 'S'. Anat Rec 1951;110:83-101.
27. Enlow DH. Normal craniofacial growth. In: Cohen MM Jr, MacLean RE, editors. Craniosynostosis, Diagnosis, Evaluation and Management, 2nd edn, eds. New York: Oxford University Press; 2000, pp. 35-50.
28. Lemire RJ. Embryology of the skull. In: Cohen, MM Jr, Maclean, RE, editors. Craniosynostosis, Diagnosis, Evaluation and Management, 2nd edn. New York. Oxford University Press; 2000. pp 24-32.
29. Moss ML. Growth of the calvaria in the rat. The determination of osseous morphology. Am J Anat 1954;94:333-62.
30. Kokich VG. The biology of sutures. In: Cohen MMJ, editor. Craniosynostosis, Diagnosis, Evaluation and Management. New York: Raven Press; 1986. pp. 81-103.
31. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Molec Cell Biol, 1999;19:1720-30.
32. Marks SC Jr, Lundmark C, Wurtz T, Odgren PR, MacKay CA, Mason-Savas A, Popoff SN. Facial development and type III collagen RNA expression: concurrent repression in the osteopetrotic (Toothless, tl) rat and rescue after treatment with colony-stimulating factor-1. Dev Dynam 1999;215:117-25.